Role of osteocytes in myeloma bone disease: anti-sclerostin antibody as new therapeutic strategy

HIGHLIGHTS

  • who: Denise Toscani from the Department Medicine and Surgery, University of Parma, Parma, Italy, Department of Biomedical, Metabolic and Neural have published the Article: Role of Osteocytes in Myeloma Bone Disease: Anti-sclerostin Antibody as New Therapeutic Strategy, in the Journal: (JOURNAL)
  • what: The aim of this review is to provide an overview of the role of osteocytes in MM bone disease describing the numerous improvements that have been made in this field.
  • how: Both pre-clinical and clinical data showed that Scl-Ab administration increased the Frontiers in Immunology | www.frontiersin.org . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?